FDA approves Biogen, Eisai Alzheimer’s drug
January 06, 2023 at 18:56 PM EST
An Alzheimer’s drug from Biogen and Eisai has received accelerated approval from the Food and Drug Administration, the companies and agency announced Friday.
Photography by Christophe Tomatis